Akèy › Twoub Jenetik
Etid klinik pou Twoub Jenetik ap rekrite nan Etazini
44 etid pou Twoub Jenetik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC12 etid
- Philadelphia, PA9 etid
- Houston, TX8 etid
- Durham, NC7 etid
- Los Angeles, CA6 etid
- Mountain View, CA6 etid
- Boston, MA6 etid
- San Diego, CA5 etid
- New York City, NY5 etid
- Miami, FL5 etid
- Columbus, OH4 etid
- Aurora, CO4 etid
- Baltimore, MD4 etid
- Dallas, TX4 etid
- Cincinnati, OH4 etid
- Chicago, IL4 etid
- Nashville, TN4 etid
- Orange, CA3 etid
- Atlanta, GA3 etid
- Oakland, CA3 etid
- Birmingham, AL3 etid
- Ann Arbor, MI3 etid
Pa eta
- Alabama3 etid
- Colorado6 etid
- Distrik Columbia3 etid
- Florid7 etid
- Georgia3 etid
- Illinois5 etid
- Kalifòni17 etid
- Maryland14 etid
- Massachusetts6 etid
- Michigan3 etid
- Minnesota5 etid
- Missouri3 etid
- New York7 etid
- North Carolina9 etid
- Ohio7 etid
- Pennsylvania11 etid
- South Carolina3 etid
- Tennessee5 etid
- Texas11 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Genome Medical Sequencing for Gene Discovery
Ap rekriteEtid obsèvasyon
4 Weeks – 99 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT01087320Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
Ap rekriteFaz 2/3
Laj 2 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT07441876Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Ap rekriteEtid obsèvasyon
1 Month – 100 Years · Tout sèks · Mizajou Sep 24, 2026 · NCT00246857Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 22, 2026 · NCT00001405Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
2 Months – 115 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT00001373Evaluation of Patients With Immune Function Abnormalities
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Sep 22, 2026 · NCT00128973Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 100 Years · Tout sèks · Mizajou Sep 18, 2026 · NCT02450851A Long-Term Observational Study of Patients With Fucosidosis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 17, 2026 · NCT07615400Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Sep 1, 2026 · NCT06016946Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
Ap rekriteEtid obsèvasyon
7 Months – 15 Months · Tout sèks · Mizajou Aug 31, 2026 · NCT06805695Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT05587439RNA to the RESCUE: Evaluation to Assess the Clinical Utility of RNA Sequencing in Establishing a Genetic Diagnosis or Adjudicating a Previously Established Genetic Diagnosis.
Ap rekriteEtid obsèvasyon
Laj 2 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07787975Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05361811Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
30 Days – 99 Years · Tout sèks · Mizajou Aug 24, 2026 · NCT01778504A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 11, 2026 · NCT07555483Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07224360Inherited Reproductive Disorders
Ap rekriteEtid obsèvasyon
6 Weeks – 120 Years · Tout sèks · Mizajou Jul 28, 2026 · NCT01500447Prospective Clinical Assessment Study in Children With Hypochondroplasia
Ap rekriteEtid obsèvasyon
30 Months – 16 Years · Tout sèks · Mizajou Jul 16, 2026 · NCT06410976Genetic and Metabolic Disease in Children
Ap rekriteEtid obsèvasyon
1 Day · Tout sèks · Mizajou Jul 2, 2026 · NCT02650622Rett Syndrome Registry
Ap rekriteEtid obsèvasyon
Laj 0 a 99 · Tout sèks · Mizajou Jun 30, 2026 · NCT05432349Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
Ap rekriteFaz 2
6 Months – 65 Years · Tout sèks · Mizajou Jun 22, 2026 · NCT03301038ARPKD Database Study
Ap rekriteEtid obsèvasyon
Jiska laj 18 · Tout sèks · Mizajou Jun 15, 2026 · NCT01401998A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT07001280UW Undiagnosed Genetic Diseases Program
Ap rekriteEtid obsèvasyon
Jiska laj 100 · Tout sèks · Mizajou May 29, 2026 · NCT04586075Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Ap rekriteFaz 3
Laj 4 a 18 · Gason · Mizajou May 27, 2026 · NCT07608432Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.